View Article

  • Bioanalytical Method Development And Validation For The Estimation Of Active Pharmaceuticals In Dosage Forms
  • 1Department of Pharmaceutical Quality Assurance, PRES College of Pharmacy (Women’s), Chincholi, Nashik422102
    2Department of Pharmaceutical Chemistry, PRES College of Pharmacy (Women’s), Chincholi, Nashik-422102

Abstract

In this review article, bioanalytical techniques are often employed to quantify pharmaceuticals and their metabolites in plasma matrices, and the techniques should be used in both human clinical investigations and nonhuman research. A key component of estimate and interpretation of bioequivalence, pharmacokinetic, and toxicokinetic investigations is the use of the bioanalytical technique for the quantitative measurement of medicines and their metabolites in biological medium. Method creation, method validation, and sample analysis are the three main responsibilities of bioanalysis. To determine the amount to which environment, matrix, or procedural factors might affect the estimation of analyte in the matrix from the time of set up to the time of analysis, each step in the technique must be examined. Techniques such as high-pressure liquid chromatography (HPLC) and liquid chromatography coupled with double mass spectrometry (LCMS-MS) can be used for the bioanalysis of drugs in body. Each of the instruments has its own merits and demerits. Chromatographic methods are HPLC and gas chromatography have been mainly used for the bioanalysis of small/ large molecules, with LC/MS/MS. Linearity, accuracy, precision, selectivity, sensitivity, reproducibility, and stability are some of the regularly used parameters. In this review article, we are proposed to add some points regarding bioanalytical method development and validation parameter, beneficial to quality assurance to determine the drug, concentration and its metabolite.

Keywords

Method development, Clinical and nonclinical study, Analyte, Validation of bioanalysis techniques, Validation parameter

Reference

  1. Thompson M, Ellison SL, Wood R. Harmonized guidelines for single laboratory validation of method of analysis. Pure Appl Chem 2008;74(5):835-55. 2
  2. Wood R. How to validate analytical methods. Trends Analyt Chem 2005;18:624-32. 
  3. Chiu ML, Lawi W, Snyder ST, Wong PK, Liao JC, Gau V. Matrix effects: A challenge toward automation of molecular analysis. J Assoc Lab Autom 2010;15:233-42. 
  4. Reid E, Wilson ID. Methodological survey in biochemistry and analysis. Analysis for Drug and Metabolites, Including Anti-Infective Agents. Vol. 20. Cambridge, England: Royal Society of Chemistry; 1990. p. 1-57. 
  5. Surendra B, DeStefano A. Key elements of bioanalytical method validation for small molecules. AAPS J 2007;9(1):109-14. 
  6. McDowall RD. The role of laboratory information management systems LIMS in analytical method validation. Anal Chim Acta 2007;54:149-58. 
  7. Vander Heyden Y, Nijhuis A, Smeyers-Verbeke J, Vandeginste BG, Massart DL. Guidance for robustness/ruggedness tests in method validation. J Pharm Biomed Anal 2001;24(5-6):723-53. 
  8. Puluido A, Ruusanches I, Boque R, Rius FX. Uncertainty of results in routine qualitative analysis in analytical chemistry. J Pharm Biomed Anal 2005;22:647-54. 
  9. Kallner A. Quality specifications based on the uncertainty of measurement. Scand J Clin Lab Invest 1999;59(7):513-6. 
  10. Rao KR, Kumar KS. Bioanalytical method validation-A quality assurance auditor view point. J Pharm Sci Res 2009;1(3):1-10. 
  11. Lang JR, Bolton S. A comprehensive method validation strategy for bioanalytical applications in the pharmaceutical industry--1. Experimental considerations. J Pharm Biomed Anal 1991;9(5):357-61. 
  12. Causon R. Validation of chromatographic methods in biomedical analysis. Viewpoint and discussion. J Chromatogr B Biomed Sci Appl 1997;689(1):175-80. 
  13. Shah VP. The history of bioanalytical method validation and regulation: Evolution of a guidance document on bioanalytical method validation. AAPS J 2007;9(1):43-7. 
  14. Buick AR, Doig MV, Jeal SC, Land GS, McDowall RD. Method validation in the bioanalytical laboratory. J Pharm Biomed Anal 1990;8(8-12):629-37. 
  15. Tiwari G, Tiwari R. Bioanalytical method validation: An updated review. Pharm Methods 2010;1(1):25-38. 
  16. Jhang JS, Chang CC, Fink DJ, Kroll MH. Evaluation of linearity in the clinical laboratory. Arch Pathol Lab Med 2004;128(1):44-8. 
  17. Mark H. Application of improved procedure for testing linearity of analytical method to pharmaceutical analsysis. J Pharm Biomed Anal 2003;33(1):7-20. 
  18. Hartmann C, Smeyers-Verbeke J, Massart DL, McDowall RD. Validation of bioanalytical chromatographic methods. J Pharm Biomed Anal 1998;17(2):193-218. 
  19. Food and Drug Administration. Guidance for Industry: Bioanalytical Method Validation. Vol. 13. Rockville, MD: U.S Department of Health and Human Services, Food and Drug Administration; 2001. p. 385-94. 
  20. Wells DA. High throughput bioanalytical sample preparation: Methods and automation strategies. Progress in Pharmaceutical and Biomedical Analysis. Vol. 30. Amsterdam, London: Elsevier; 2003. p. 610.
  21. Karnes HT, Shiu G, Shah VP. Validation of bioanalytical methods. Pharm Res 1991;8(4):421-6. 
  22. Kringle RO. An assessment of the 4-6-20 rule of acceptance of analytical runs in bioavailability, bioequivalence, and pharmacokinetic studies. Pharm Res 1994;11(4):556-60. 
  23. Wieling J, Hendriks G, Tamminga WJ, Hempenius J, Mensink CK, Oosterhuis B, et al. Rational experimental design for bioanalytical methods validation. Illustration using an assay method for total captopril in plasma. J Chromatogr A 1996;730(1-2):381-94. 
  24. Kringle R, Hoffman D. Stability methods for assessing stability of compounds in whole blood for clinical bioanalysis. Drug Inf J 2001;35:1261-70. 
  25. Viswanathan CT, Bansal S, Booth B, DeStefano AJ, Rose MJ, Sailstad J, et al. Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays. AAPS J 2007;9(2):E260-7. 
  26. Singh PS, Shah G. Analytical method development and validation. J Pharm Res 2011;4(5):2330-2. 
  27. Dadgar D, Burnett PE. Issues in evaluation of bioanalytical method selectivity and drug stability. J Pharm Biomed Anal 1995;14(1-2):23-31. 
  28. Miller KJ, Bowsher RR, Celniker A, Gibbons J, Gupta S, Lee JW, et al. Workshop on bioanalytical methods validation for macromolecules: Summary report. Pharm Res 2001;18(9):1373-83. 
  29. Hubert H, Chiap P, Crommen J, Boulanger B, Chapuzet E, Mercier N, et al. The SFSTP guide on the validation of chromatographic methods for drug analysis: From the Washington Conference to the laboratory. Anal Chim Acta 1999;391:45-55. 
  30. Timm U, Wall M, Dell D. A new approach for dealing with the stability of drugs in biological fluids. J Pharm Sci 1985;74(9):972-7.
  31. Nowatzke W, Woolf E. Best practices during bioanalytical method validation for the characterization of assay reagents and the evaluation of analyte stability in assay standards, quality controls, and study samples. AAPS J 2007;9(2):E117-22. 
  32. Braggio S, Barnaby RJ, Grossi P, Cugola M. A strategy for validation of bioanalytical methods. J Pharm Biomed Anal 1996;14(4):375-88.
  33. James CA, Breda M, Frigerio E. Bioanalytical method validation: Arisk-based approach? J Pharm Biomed Anal 2004;35(4):887-93. 
  34. Boulanger B, Chiap P, Dewe W, Crommen J, Hubert P. An analysis of the SFSTP guide on validation of chromatographic bioanalytical methods: Progresses and limitations. J Pharm Biomed Anal 2005;32(4-5):753-65.

Photo
Neha Gaikwad
Corresponding author

Department of Pharmaceutical Quality Assurance, PRES College of Pharmacy (Women’s), Chincholi, Nashik422102

Photo
Kanchan Shinde
Co-author

Department of Pharmaceutical Quality Assurance, PRES College of Pharmacy (Women’s), Chincholi, Nashik422102

Photo
Varsha Pangale
Co-author

Department of Pharmaceutical Quality Assurance, PRES College of Pharmacy (Women’s), Chincholi, Nashik422102

Photo
Charushila Bhangale
Co-author

Department of Pharmaceutical Chemistry, PRES College of Pharmacy (Women’s), Chincholi, Nashik-422102

Neha Gaikwad*, Kanchan Shinde, Varsha Pangale, Charushila Bhangale, Bioanalytical Method Development And Validation For The Estimation Of Active Pharmaceuticals In Dosage Forms, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 3, 143-152. https://doi.org/10.5281/zenodo.7755584

More related articles
Recent Advanced In Cromatographic Techniques For A...
Kavita Suresh Hamare, R. B. Darade, ...
A Comparative Evaluation Of Compressive Strength O...
Bhargav Chitroda, Kailash Attur, Nikunj Patel, Dhruvi Pandya, Mok...
A Review On The Role of Angiotensin Receptor-Nepri...
TUPE CHAITANYA KHANDERAO , Kisshor Vasant Otarri , Ajay Kale , ...
Formulation and Optimization of Natural Anti-Inflammatory Cream Using Herbal Ext...
Kute Swamini Bhaskar, Harsh Yogesh Meher , Swapnil Kale, ...
Regulating Artificial Intelligence: Developments And Challenges...
Durga Chavali, Biju Baburajan, Ashokkumar Gurusamy, Vinod Kumar Dhiman, Siri Chandana Katari, ...
Related Articles
Breathless: A Comprehensive Study Of Pathophysiology, Diagnosis, And Treatment O...
Hema Arya, Shelesh Kumar Bansal, Tanuj Bhardwaj , Kanishk, Shivam, ...
Method Development and Validation for The Simultaneous Estimation of Pioglitazon...
Dr PV Madhavi Latha , Dr B. NAGAMANI, Dr P. Umadevi, A.Umasai chaitnya, Pyla Sivalalitha , ...
More related articles
A Comparative Evaluation Of Compressive Strength Of Two Universal Composite Stor...
Bhargav Chitroda, Kailash Attur, Nikunj Patel, Dhruvi Pandya, Moksha Shah, Shlesha Sheth, ...
A Review On The Role of Angiotensin Receptor-Neprilysin Inhibitors in Heart Fail...
TUPE CHAITANYA KHANDERAO , Kisshor Vasant Otarri , Ajay Kale , ...
A Comparative Evaluation Of Compressive Strength Of Two Universal Composite Stor...
Bhargav Chitroda, Kailash Attur, Nikunj Patel, Dhruvi Pandya, Moksha Shah, Shlesha Sheth, ...
A Review On The Role of Angiotensin Receptor-Neprilysin Inhibitors in Heart Fail...
TUPE CHAITANYA KHANDERAO , Kisshor Vasant Otarri , Ajay Kale , ...